Articles liés à Adenosine, Cardioprotection, and Its Clinical Application

Adenosine, Cardioprotection, and Its Clinical Application - Couverture rigide

 
9780792399544: Adenosine, Cardioprotection, and Its Clinical Application

Synopsis

It has been almost 15 years since the fIrst reports appeared indicating that adenosine exerted a .protective effect in ischemic and reperfused myocardium. Numerous experimental studies have shown that adenosine (both exogenous and endogenous adenosine) delays the onset of ischemic contracture, modulates myocardial metabolism during ischemia, attenuates reversible postischemic ventricular dysfunction (myocardial stunning), and reduces myocardial infarct size. Initial studies on adenosine's cardioprotective effect were based on its ability to stimulate postischemic ATP resynthesis, increase coronary blood flow, and reduce heart rate. Although these actions of adenosine are undoubtedly benefIcial to the ischemic/reperfused heart, it now appears that adenosine's cardioprotective effect may be exclusive of these properties. The immense growth in the number of articles on adenosine cardioprotection in the last several years has been related in large part to the hypothesis that adenosine plays a role in ischemic preconditioning. Ischemic preconditioning is the phenomenon in which a brief period of ischemia (and reperfusion) prior to a more prolonged occlusion reduces myocardial infarct size. This form of myocardial protection has received much interest because ischemic preconditioning has been shown to be the most potent means of reducing infarct size in all animal models thus far tested. In fact prior to studies implicating adenosine's role in ischemic preconditioning, adenosine's infarct reducing effect was not well recognized.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Acheter neuf

Afficher cet article
EUR 170,57

Autre devise

EUR 4,75 expédition depuis Royaume-Uni vers France

Destinations, frais et délais

Autres éditions populaires du même titre

9781461346760: Adenosine, Cardioprotection and Its Clinical Application

Edition présentée

ISBN 10 :  1461346762 ISBN 13 :  9781461346760
Editeur : Springer, 2012
Couverture souple

Résultats de recherche pour Adenosine, Cardioprotection, and Its Clinical Application

Image d'archives

Edité par Springer, 1997
ISBN 10 : 0792399544 ISBN 13 : 9780792399544
Neuf Couverture rigide

Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Etat : New. In. N° de réf. du vendeur ria9780792399544_new

Contacter le vendeur

Acheter neuf

EUR 170,57
Autre devise
Frais de port : EUR 4,75
De Royaume-Uni vers France
Destinations, frais et délais

Quantité disponible : Plus de 20 disponibles

Ajouter au panier

Image fournie par le vendeur

Mentzer, Robert M.|Kitakaze, Masafumi|Downey, James M.|Hori, Masatsugu
Edité par Springer US, 1997
ISBN 10 : 0792399544 ISBN 13 : 9780792399544
Neuf Couverture rigide

Vendeur : moluna, Greven, Allemagne

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Gebunden. Etat : New. I: Adenosine and Cardioprotection. 1. Adenosine and Cardioprotection R.M. Mentzer, Jr., R. Lasley. II: Cardioprotection and Mechanisms of Ischemic And Reperfusion Injury. 2. Concept of Cardioprotection Against Myocardial Ischemia M. Hori. 3. The Late . N° de réf. du vendeur 458444093

Contacter le vendeur

Acheter neuf

EUR 178,14
Autre devise
Frais de port : EUR 9,70
De Allemagne vers France
Destinations, frais et délais

Quantité disponible : Plus de 20 disponibles

Ajouter au panier

Image d'archives

Edité par Springer, 1997
ISBN 10 : 0792399544 ISBN 13 : 9780792399544
Neuf Couverture rigide

Vendeur : Lucky's Textbooks, Dallas, TX, Etats-Unis

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Etat : New. N° de réf. du vendeur ABLIING23Feb2416190186335

Contacter le vendeur

Acheter neuf

EUR 162,98
Autre devise
Frais de port : EUR 66,48
De Etats-Unis vers France
Destinations, frais et délais

Quantité disponible : Plus de 20 disponibles

Ajouter au panier

Image fournie par le vendeur

Robert M Mentzer Jr
Edité par Springer Us Jun 1997, 1997
ISBN 10 : 0792399544 ISBN 13 : 9780792399544
Neuf Couverture rigide

Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Buch. Etat : Neu. Neuware - It has been almost 15 years since the fIrst reports appeared indicating that adenosine exerted a .protective effect in ischemic and reperfused myocardium. Numerous experimental studies have shown that adenosine (both exogenous and endogenous adenosine) delays the onset of ischemic contracture, modulates myocardial metabolism during ischemia, attenuates reversible postischemic ventricular dysfunction (myocardial stunning), and reduces myocardial infarct size. Initial studies on adenosine's cardioprotective effect were based on its ability to stimulate postischemic ATP resynthesis, increase coronary blood flow, and reduce heart rate. Although these actions of adenosine are undoubtedly benefIcial to the ischemic/reperfused heart, it now appears that adenosine's cardioprotective effect may be exclusive of these properties. The immense growth in the number of articles on adenosine cardioprotection in the last several years has been related in large part to the hypothesis that adenosine plays a role in ischemic preconditioning. Ischemic preconditioning is the phenomenon in which a brief period of ischemia (and reperfusion) prior to a more prolonged occlusion reduces myocardial infarct size. This form of myocardial protection has received much interest because ischemic preconditioning has been shown to be the most potent means of reducing infarct size in all animal models thus far tested. In fact prior to studies implicating adenosine's role in ischemic preconditioning, adenosine's infarct reducing effect was not well recognized. N° de réf. du vendeur 9780792399544

Contacter le vendeur

Acheter neuf

EUR 247,94
Autre devise
Frais de port : EUR 10,99
De Allemagne vers France
Destinations, frais et délais

Quantité disponible : 2 disponible(s)

Ajouter au panier